Lenzing's Nine-Month Cash Squeeze Tests Whether 120 Million Euros in Savings Can Fund the Turnaround

Lenzing has spent the past two weeks telling investors it has the money to finish its restructuring. The nine-month report published today shows why that money matters: the free cash flow collapsed to 24.7 million euros from 110.9 million euros a year earlier, even as adjusted earnings held their ground.

That gap between profit and cash is the crux of the story. Adjusted EBITDA came in at 353 million euros, essentially flat year on year, and the adjusted margin actually improved to 18.3% from 17.9%. Revenue slipped 2.3% to 1.926 billion euros — a decline the company attributes partly to deliberately scaling back standard fibre production and partly to lower pulp prices. Less revenue, in other words, is not purely a demand signal; it also reflects the intended shift in the product mix.

Operating cash flow also weakened, landing at 206.2 million euros. A stabilised operating result, the figures make plain, does not automatically translate into equally strong internal financing.

What the headline loss actually contains

Restructuring effects of 36.6 million euros pulled reported EBITDA down to 316.4 million euros. On top of that, non-cash impairments on Heiligenkreuz and Grimsby hit EBIT to the tune of 136.1 million euros. The distinction matters: the write-downs weigh on EBIT but not on EBITDA, and because they never touched cash, they do not by themselves explain the weaker free cash flow.

Should investors sell immediately? Or is it worth buying Lenzing?

The bottom line showed a net loss of 130.3 million euros, wider than the 105 million euros recorded a year earlier. Strip out the impairments and restructuring and Lenzing says it would have posted a net profit of 42.4 million euros.

Financing: banked, promised, and still provisional

The balance sheet metrics — net financial debt of 1,418.9 million euros, an adjusted equity ratio of 26.6% and liquidity of 562.0 million euros — all reflect the position at the end of September, before the capital increase took effect. They should not be read as an already repaired capital base.

That increase, effective roughly two weeks ago, raised about 300 million euros, according to Kurier. A further 300 million euros is slated to come from new financing arrangements, of which only about half was firmly committed. The caveat is central to any valuation: not the entire headline financing volume was secured on binding terms. Nor does fresh equity remove the task of lifting free cash flow from the day-to-day business.

The savings programme behind the plan

Underpinning the whole effort is a pledge Lenzing reaffirmed today: an additional 120 million euros in cost savings by the end of 2027, measured against the 2025 cost base. The programme includes roughly 600 job cuts. Production at Heiligenkreuz is to stop by the end of the first quarter of 2027, with Grimsby scheduled to follow by the end of that year.

Strategically, Lenzing wants to expand its nonwovens business and push textile fibres toward premium and specialty products, retreating from low-margin standard fibres. The logic is a more profitable mix rather than growth at any price — but the restructuring is currently weighing on reported results, and announced savings are not yet proof of a completed turnaround.

Lenzing at a turning point? This analysis reveals what investors need to know now.

Management is targeting adjusted EBITDA of 430–460 million euros for 2026. Over the medium term it is aiming for an EBITDA margin of 20–25%, an EBITDA improvement of 150 million euros and a leverage ratio below 2.5.

Those are ambitions, not achievements. For shareholders, the decisive question is whether better margins can be converted into stronger free cash flow and a lighter debt load. The capital increase has strengthened the starting position; only the combination of improved profitability, rising cash generation and falling borrowings would demonstrate that the rebuild can stand on its own.

Ad

Lenzing Stock: New Analysis - 5 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...